Local stem cell biotech Mesoblast wins key US investor backing – The Sydney Morning Herald
The Sydney Morning HeraldLocal stem cell biotech Mesoblast wins key US investor backingThe Sydney Morning HeraldOut-of-favour stem cell company Mesoblast has won significant backing for its technology from major US drug group Mallinckrodt Pharmaceutica… Continue reading
